TERNS PHARMACEUTICALS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by TERNS PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2024-03-07Point72 Asset Management, L.P.Terns Pharmaceuticals, Inc.3,881,3416.3%EDGAR
SC 13G/A2024-02-14Fairmount Funds Management LLCTerns Pharmaceuticals, Inc.6,632,0159.9%EDGAR
SC 13G/A2024-02-14Venrock Healthcare Capital Partners III, L.P.Terns Pharmaceuticals, Inc.4,497,1177.3%EDGAR
SC 13G/A2024-02-14Deep Track Capital, LPTerns Pharmaceuticals, Inc.6,100,0009.9%EDGAR
SC 13G/A2024-02-13SUVRETTA CAPITAL MANAGEMENT, LLCTerns Pharmaceuticals, Inc.5,837,1269.5%EDGAR
SC 13G/A2024-02-13LAV Biosciences Fund V, L.P.Terns Pharmaceuticals, Inc.919,5231.5%EDGAR
SC 13G/A2024-02-09FMR LLCTerns Pharmaceuticals, Inc.2,990,4024.8%EDGAR
SC 13G2024-01-31BlackRock Inc.Terns Pharmaceuticals, Inc.3,408,9785.5%EDGAR
SC 13G2024-01-25INTEGRATED CORE STRATEGIES (US) LLCTerns Pharmaceuticals, Inc.3,434,1785.6%EDGAR
SC 13G/A2023-10-13FMR LLCTerns Pharmaceuticals, Inc.5,118,0508.4%EDGAR
SC 13G/A2023-10-04Flynn James ETerns Pharmaceuticals, Inc.00.0%EDGAR
SC 13G2023-07-28Deep Track Capital, LPTerns Pharmaceuticals, Inc.3,560,0006.3%EDGAR
SC 13G2023-06-27MILLENNIUM MANAGEMENT LLCTerns Pharmaceuticals, Inc.2,313,3704.1%EDGAR
SC 13D/A2023-03-29ORBIMED ADVISORS LLCTerns Pharmaceuticals, Inc.7,619,13513.4%EDGAR
SC 13G/A2023-02-14Fairmount Funds Management LLCTerns Pharmaceuticals, Inc.5,269,2879.9%EDGAR
SC 13G/A2023-02-14Venrock Healthcare Capital Partners III, L.P.Terns Pharmaceuticals, Inc.3,707,8917.7%EDGAR
SC 13G/A2023-02-14Vivo Capital VIII, LLCTerns Pharmaceuticals, Inc.2,317,7804.8%EDGAR
SC 13G/A2023-02-13Auspice LtdTerns Pharmaceuticals, Inc.941,2062.0%EDGAR
SC 13G/A2023-02-10Flynn James ETerns Pharmaceuticals, Inc.2,851,2875.8%EDGAR
SC 13G/A2023-02-09FMR LLCTerns Pharmaceuticals, Inc.7,378,64114.9%EDGAR
External links